Consideration of use of neuraminidase inhibitors such as oseltamivir and zanamivir in IgA nephropathy
- 1 December 2005
- journal article
- Published by Elsevier in Kidney International
- Vol. 68 (6) , 2910-2911
- https://doi.org/10.1111/j.1523-1755.2005.00583_7.x
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathyKidney International, 2005
- Aberrant glycosylation in IgA nephropathy (IgAN)Kidney International, 2004
- Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in miceBrain Research, 2003
- InfluenzaThe Lancet, 2003